psychedelics

New Orleans Hosts Psychedelic Research Conference Double-Header
Turning On The Culture
New Federal Bill Aims to Establish VA Office of Novel Therapeutics
Federal Support for U.S. Psychedelic Research Accelerates 5-MeO-DMT Clinical Trials
Beyond FDA Approval: Psychedelics as Catalysts For Creativity and Innovation 
Oregon’s Psilocybin Program: Industry Insiders Weigh In On Closures and the Future
Varying Approaches to Psychedelic Policy Reform in Washington State
Legislation, Industry, and the Future of Psilocybin for PTSD 
New Theories and Findings From The Frontier of Ibogaine Research 
NJ Psilocybin Legislation Exposes Conflicts Between Advocates for Different Therapeutic  Models